Targeted inhibition of eIF5Ahpu suppresses tumor growth and polarization of M2-like tumor-associated macrophages in oral cancer

被引:9
|
作者
Zeng, Jincheng [1 ,2 ]
Ye, Ziyu [1 ,2 ]
Shi, Shihong [1 ]
Liang, Yanfang [3 ]
Meng, Qingyu [1 ]
Zhang, Qunzhou [1 ]
Le, Anh D. [1 ,4 ]
机构
[1] Univ Penn, Sch Dent Med, Dept Oral & Maxillofacial Surg & Pharmacol, Philadelphia, PA 19104 USA
[2] Guangdong Med Univ, Dongguan Key Lab Med Bioact Mol Dev & Translat Res, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan 523808, Peoples R China
[3] Jinan Univ, Dongguan Hosp, Binhaiwan Cent Hosp Dongguan, Dept Pathol, Dongguan 523905, Peoples R China
[4] Univ Penn, Penn Med Hosp, Perelman Ctr Adv Med, Dept Oral & Maxillofacial Surg, Philadelphia, PA 19104 USA
关键词
SQUAMOUS-CELL CARCINOMA; NECK-CANCER; MESENCHYMAL TRANSITION; OROPHARYNGEAL CANCER; HEAD; INITIATION; RECURRENT; HYPUSINE; THERAPY; PROGRESSION;
D O I
10.1038/s41419-023-06109-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Eukaryotic initiation factor 5A2 (eIF5A2) is overexpressed in many types of cancer, and spermidine-mediated eIF5A hypusination (eIF5A(hpu)) appears to be essential to most of eIF5A's biological functions, including its important role in regulating cancer cell proliferation, epithelial-mesenchymal transition (EMT), and cancer stem cell (CSC) properties as well as immune cell functions. Here we investigated the role of eIF5A(hpu) in the growth of oral squamous cell carcinoma cells (OSCCs) and OSCC-induced polarization of M2-like tumor-associated macrophages (TAMs). TCGA dataset analysis revealed an overall upregulation in the mRNA expression of eIF5A2 and several key enzymes involved in polyamine (PA) metabolism in HNSCC, which was confirmed by Western blot and IHC studies. Blocking eIF5A(hpu) by GC-7 but not the upstream key enzyme activities of PA metabolism, remarkably inhibited cell proliferation and the expression of EMT- and CSC-related genes in OSCC cells. In addition, blocking eIF5A(hpu) robustly inhibited OSCC-induced M2-like TAM polarization in vitro. More Importantly, blocking eIF5A(hpu) dramatically retarded tumor growth and infiltration/polarization of M2-like TAM in a syngeneic orthotopic murine tongue SCC model. Thus, eIF5A(hpu) plays dual functions in regulating tumor cell growth and polarization of M2-TAMs in OSCC.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer
    Loi, M.
    Salvatore, G.
    Sottili, M.
    Calosi, L.
    Desideri, I
    Becherini, C.
    Salvestrini, V
    Ciccone, L. P.
    Stocchi, G.
    Meattini, I
    Francolini, G.
    Mangoni, M.
    Livi, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (07) : 1395 - 1402
  • [32] Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813
    Melancon, Marites P.
    Lu, Wei
    Huang, Qian
    Thapa, Prakash
    Zhou, Dapeng
    Ng, Chaan
    Li, Chun
    BIOMATERIALS, 2010, 31 (25) : 6567 - 6573
  • [33] Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer
    Di Mitri, Diletta
    Mirenda, Michela
    Vasilevska, Jelena
    Calcinotto, Arianna
    Delaleu, Nicolas
    Revandkar, Ajinkya
    Gil, Veronica
    Boysen, Gunther
    Losa, Marco
    Mosole, Simone
    Pasquini, Emiliano
    D'Antuono, Rocco
    Masetti, Michela
    Zagato, Elena
    Chiorino, Giovanna
    Ostano, Paola
    Rinaldi, Andrea
    Gnetti, Letizia
    Graupera, Mariona
    Figueiredo Fonseca, Ana Raquel Martins
    Mestre, Ricardo Pereira
    Waugh, David
    Barry, Simon
    De Bono, Johann
    Alimonti, Andrea
    CELL REPORTS, 2019, 28 (08): : 2156 - +
  • [34] M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression
    Zeng, Xiang-Yang
    Xie, Hui
    Yuan, Jing
    Jiang, Xiao-Yan
    Yong, Jia-Hui
    Zeng, Da
    Dou, Ying-Yu
    Xiao, Song-Shu
    CANCER BIOLOGY & THERAPY, 2019, 20 (07) : 956 - 966
  • [35] LINC00337 induces tumor development and chemoresistance to paclitaxel of breast cancer by recruiting M2 tumor-associated macrophages
    Xing, Zeyu
    Zhang, Menglu
    Liu, Jiaqi
    Liu, Gang
    Feng, Kexin
    Wang, Xiang
    MOLECULAR IMMUNOLOGY, 2021, 138 : 1 - 9
  • [36] The prognostic role of M2 tumor-associated macrophages in non-small-cell lung cancer
    Li, Zhuo
    Wang, Yun-jie
    Zhou, Jian
    Umakoshi, Michinobu
    Goto, Akiteru
    HISTOLOGY AND HISTOPATHOLOGY, 2022, 37 (12) : 1167 - 1175
  • [37] All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
    Zhou, Qian
    Xian, Miao
    Xiang, Senfeng
    Xiang, Danyan
    Shao, Xuejing
    Wang, Jincheng
    Cao, Ji
    Yang, Xiaochun
    Yang, Bo
    Ying, Meidan
    He, Qiaojun
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (07) : 547 - 559
  • [38] Multifunctional Nanodrug-Mediated Immunotherapy in Microsatellite Stable Colorectal Cancer via Promoting m6A Modification and M1-Like Tumor-Associated Macrophages Polarization
    Li, Caiying
    Chen, Gengjia
    Li, Tan
    Xie, Peiyi
    Ma, Decai
    Yang, Long
    Xiao, Zecong
    Shuai, Xintao
    Meng, Xiaochun
    SMALL STRUCTURES, 2024, 5 (10):
  • [39] Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer
    Deng, Yan
    Hu, Jia-chun
    He, Shu-hua
    Lou, Bin
    Ding, Ting-bo
    Yang, Jin-tong
    Mo, Ming-guang
    Ye, De-yong
    Zhou, Lu
    Jiang, Xian-cheng
    Yu, Ker
    Dong, Ji-bin
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (01) : 149 - 159
  • [40] COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
    Nakanishi, Yuki
    Nakatsuji, Masato
    Seno, Hiroshi
    Ishizu, Shoko
    Akitake-Kawano, Reiko
    Kanda, Keitaro
    Ueo, Taro
    Komekado, Hideyuki
    Kawada, Mayumi
    Minami, Manabu
    Chiba, Tsutomu
    CARCINOGENESIS, 2011, 32 (09) : 1333 - 1339